ArticleInternational journal of nanomedicine

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.

Dan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.